Evidence map›Paper›PMID 30018108›Full record

ArticlemBio2018

Liver X Receptors Suppress Activity of Cholesterol and Fatty Acid Synthesis Pathways To Oppose Gammaherpesvirus Replication.

P T Lange, C Schorl, D Sahoo, V L Tarakanova

Open access · goldAbstract read
In one paragraph

Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

P T LangeDepartment of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
C SchorlDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, Rhode Island, USA.
D SahooDivision of Endocrinology, Metabolism and Clinical Nutrition, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
V L TarakanovaDepartment of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA vera@mcw.edu.
Medical College of Wisconsin · USBrown University · US

Funding

UTERINE NK CELL HOMING FROM THE PERIPHERAL CIRCULATIONP20RR018728 · NCRR · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI BLISS, JOSEPH MARK · 2003 to 2011
$16.7M
Selective Uptake and Hydrolysis of Cholesteryl Ester by SR-BIR01HL058012 · NHLBI · STATE UNIVERSITY NEW YORK STONY BROOK · PI SAHOO, DAISY · 1997 to 2023
$8.6M
Center for Cancer Signaling NetworksP30GM103410 · NIGMS · BROWN UNIVERSITY · PI ATWOOD, WALTER J · 2012 to 2015
$4.3M
IRF-1: a brake to limit gammaherpesvirus infection and pathogenesisR01CA203923 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI TARAKANOVA, VERA L. · 2017 to 2021
$2.0M
ATM and gammaherpesvirus infection: a precarious balanceR01CA183593 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI TARAKANOVA, VERA L. · 2014 to 2018
$1.6M
CENTER FOR CANCER SIGNALING NETWORKSP30RR031153 · NCRR · BROWN UNIVERSITY · PI ATWOOD, WALTER J · 2011 to 2011
$1.1M
Chronic gammaherpesvirus infection and high cholesterol: Adding fuel to the fireR21AI147500 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI SAHOO, DAISY, TARAKANOVA, VERA L. · 2020 to 2021
$424k
NCI NIH HHS R01 CA183593NCI NIH HHS R01 CA203923NCRR NIH HHS P20 RR018728NCRR NIH HHS P30 RR031153NHLBI NIH HHS R01 HL058012NIAID NIH HHS R21 AI147500NIGMS NIH HHS P30 GM103410
6 · The paper itself

Abstract

Gammaherpesviruses are oncogenic pathogens that persist in ~95% of the adult population. Cellular metabolic pathways have emerged as important regulators of many viral infections, including infections by gammaherpesviruses that require several lipid synthetic pathways for optimal replication. Liver X receptors (LXRs) are transcription factors that are critical regulators of cellular fatty acid and cholesterol synthesis pathways. Not surprisingly, LXRs are attractive therapeutic targets in cardiovascular disease. Here we describe an antiviral role for LXRs in the context of gammaherpesvirus infection of primary macrophages. We show that type I interferon increased LXR expression following infection. Surprisingly, there was not a corresponding induction of LXR target genes. Rather, LXRs suppressed the expression of target genes, leading to decreased fatty acid and cholesterol synthesis, two metabolic pathways that support gammaherpesvirus replication. This report defines LXR-mediated restriction of cholesterol and lipid synthesis as an intrinsic metabolic mechanism to restrict viral replication in innate immune cells.

Indexed as

Host-Pathogen InteractionsVirus ReplicationAnimalsAntiviral AgentsBiosynthetic PathwaysCells, CulturedCholesterolDNA, ViralFatty AcidsGammaherpesvirinaeGene ExpressionInterferon Type ILiver X ReceptorsMacrophagesMice, Inbred C57BLRNA, MessengerAntiviral AgentsCholesterolDNA, ViralFatty AcidsInterferon Type ILiver X ReceptorsRNA, Messengercholesterol synthesisfatty acid synthesisgammaherpesvirusliver X receptorsmacrophages

Identifiers

PMID30018108
PMCPMC6050960
OpenAlexW2884837880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.